{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:47:23Z","timestamp":1786654043225,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejphar.2026.179186","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:22:56Z","timestamp":1785280976000},"page":"179186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model"],"prefix":"10.1016","volume":"1031","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9179-7418","authenticated-orcid":false,"given":"Qianqian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4288-9074","authenticated-orcid":false,"given":"Xiaobo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-9738","authenticated-orcid":false,"given":"Huabing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-5168","authenticated-orcid":false,"given":"Xiangjian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179186_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1227\/neu.0000000000003459","volume":"98","author":"Akers","year":"2026","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejphar.2026.179186_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1158\/1078-0432.CCR-24-2464","article-title":"Phase Ib clinical and pharmacodynamic study of the TIE2 kinase inhibitor rebastinib with paclitaxel or eribulin in HER2-Negative metastatic breast cancer","volume":"31","author":"Anampa","year":"2025","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179186_bib3","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200121","article-title":"Role of rho-associated kinase in the pathophysiology of cerebral cavernous malformations","volume":"10","author":"Ayata","year":"2024","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ejphar.2026.179186_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf408","article-title":"Clinical and molecular landscape of paediatric cerebral and spinal cavernous malformations","volume":"7","author":"Benichi","year":"2025","journal-title":"Brain Commun."},{"key":"10.1016\/j.ejphar.2026.179186_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/426952","article-title":"Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations","volume":"76","author":"Bergametti","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2026.179186_bib6","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI44393","article-title":"Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice","volume":"121","author":"Chan","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.179186_bib7","article-title":"Micro-CT imaging reveals Mekk3 heterozygosity prevents cerebral cavernous malformations in Ccm2-Deficient mice","volume":"11","author":"Choi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179186_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau0731","article-title":"Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations","volume":"4","author":"Choi","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2026.179186_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110438","article-title":"PDCD10 gene mutations in multiple cerebral cavernous malformations","volume":"9","author":"Cigoli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179186_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2016.152710","article-title":"Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia","volume":"102","author":"Cortes","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2026.179186_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105642","article-title":"Role of pericytes in the development of cerebral cavernous malformations","volume":"25","author":"Dai","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.ejphar.2026.179186_bib12","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213798","article-title":"Lifetime risk of first symptomatic ICH or seizure in familial cerebral cavernous malformations: a multicenter patient data analysis","volume":"105","author":"Dammann","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2026.179186_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1086\/381718","article-title":"Mutations within the MGC4607 gene cause cerebral cavernous malformations","volume":"74","author":"Denier","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2026.179186_bib14","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.21873\/anticanres.16428","article-title":"The suppressive effect of rebastinib on triple-negative breast cancer tumors involves multiple mechanisms of action","volume":"43","author":"Feng","year":"2023","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2026.179186_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jamaneurol.2017.0439","article-title":"Population-based prevalence of cerebral cavernous malformations in older adults: Mayo clinic study of aging","volume":"74","author":"Flemming","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejphar.2026.179186_bib16","doi-asserted-by":"crossref","first-page":"15774","DOI":"10.1021\/jacs.8b08048","article-title":"Binding kinetics survey of the drugged kinome","volume":"140","author":"Georgi","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2026.179186_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbrc.2022.02.001","article-title":"Structural study of ponatinib in inhibiting SRC kinase","volume":"598","author":"Guo","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.179186_bib19","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200140","article-title":"Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican","volume":"217","author":"Hong","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.179186_bib20","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm100395q","volume":"53","author":"Huang","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179186_bib21","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/jama.2025.0220","article-title":"Chronic myeloid leukemia: a review","volume":"333","author":"Jabbour","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2026.179186_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/13815","article-title":"Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas","volume":"23","author":"Laberge-le Couteulx","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2026.179186_bib23","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20251374","article-title":"TIE2 links MEKK3-KLF2\/4 and PI3K signaling in cerebral cavernous malformation","volume":"223","author":"Li","year":"2026","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.179186_bib24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/380314","article-title":"Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations","volume":"73","author":"Liquori","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2026.179186_bib25","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.216093","article-title":"The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity","volume":"131","author":"Lisowska","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2026.179186_bib26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041188","article-title":"Endothelial cell-pericyte interactions in the pathogenesis of cerebral cavernous malformations (CCMs)","volume":"13","author":"Min","year":"2023","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejphar.2026.179186_bib27","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.celrep.2015.02.052","article-title":"Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1","volume":"10","author":"Najjar","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.179186_bib28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0271678X20943823","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2026.179186_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/17474086.2016.1232163","article-title":"Ponatinib in the therapy of chronic myeloid leukemia","volume":"9","author":"Poch Martell","year":"2016","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.ejphar.2026.179186_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCRESAHA.118.312981","article-title":"Genetic targeting of organ-specific blood vessels","volume":"123","author":"Pu","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179186_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000350042","article-title":"CCM3 mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas","volume":"4","author":"Riant","year":"2013","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.ejphar.2026.179186_bib32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMra2305116","article-title":"Cavernous malformations of the central nervous system","volume":"390","author":"Smith","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179186_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.125.073610","article-title":"Ponatinib, but not the new Abl-kinase inhibitor asciminib, activates platelets, leukocytes, and endothelial cell TNF signaling to induce atherosclerotic plaque inflammation, myocardial infarction, and stroke","volume":"152","author":"Stepanian","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179186_bib34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3171\/jns.2005.103.5.0903","article-title":"Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations","volume":"103","author":"Tu","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejphar.2026.179186_bib35","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population","volume":"357","author":"Vernooij","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179186_bib36","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ajhg.2021.04.005","article-title":"Somatic MAP3K3 mutation defines a subclass of cerebral cavernous malformation","volume":"108","author":"Weng","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2026.179186_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm.1911","article-title":"The cerebral cavernous malformation signaling pathway promotes vascular integrity via rho GTPases","volume":"15","author":"Whitehead","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179186_bib38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/STROKEAHA.124.049935","article-title":"Map3k3 (I441M) Knock-In mouse model of cerebral cavernous malformations","volume":"56","author":"Xu","year":"2025","journal-title":"Stroke J. Cerebral Circ."},{"key":"10.1016\/j.ejphar.2026.179186_bib39","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1177\/0271678X221105995","article-title":"Cerebral cavernous malformation development in chronic mouse models driven by dual recombinases induced gene deletion in brain endothelial cells","volume":"42","author":"Yang","year":"2022","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2026.179186_bib40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.07.006","article-title":"BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia","volume":"26","author":"Zabriskie","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179186_bib41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/adt.2009.0222","article-title":"ADP-Glo: a bioluminescent and homogeneous ADP monitoring assay for kinases","volume":"7","author":"Zegzouti","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.ejphar.2026.179186_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41467-020-20774-0","article-title":"Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model","volume":"12","author":"Zhou","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179186_bib42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.devcel.2014.12.009","article-title":"The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression","volume":"32","author":"Zhou","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2026.179186_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature17178","article-title":"Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling","volume":"532","author":"Zhou","year":"2016","journal-title":"Nature"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:16:18Z","timestamp":1786652178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S0014299926006680"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179186","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179186"}}